1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. X.T.L. BIOPHARMACEUTICALS LTD. - ADR
X.T.L. Biopharmaceuticals Ltd. - ADR XNAS: XTLB

X.T.L. Biopharmaceuticals Ltd. - ADR Live Share Price Today, Share Analysis and Chart

about

XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a m...

Read More
0.95 -0.27 (-22.13%)
Near 52W Low of $0.92
18,982
XNAS Volume
High vol.+loss this week

XNAS 20 Jun, 2025 4:16 PM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for X.T.L. Biopharmaceuticals Ltd. - ADR is on 24 Jun 2025 for the purpose of XTL Biopharmaceuticals Ltd First Quarter Earnings Results for 2025 See details
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
12.3 / 100
Momentum Score
Technically Bearish
32.7 / 100
Analyst Price Target
No estimates available

7

S

17

W

1

O

0

T

SWOT Analysis

X.T.L. Biopharmaceuticals ... Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

X.T.L. Biopharmaceuticals Ltd. - ADR FAQ

How is X.T.L. Biopharmaceuticals Ltd. - ADR today?
X.T.L. Biopharmaceuticals Ltd. - ADR today is trading in the red, and is down by -22.13% at 0.95.
X.T.L. Biopharmaceuticals Ltd. - ADR is currently trading down -22.13% on an intraday basis. In the past week the stock fell -15.18%. stock has been down -18.80% in the past quarter and fell -57.59% in the past year. You can view this in the overview section.